Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1981 1
1983 1
1984 2
1986 1
1987 1
1988 2
1990 2
1994 2
1995 2
2000 4
2001 2
2002 4
2003 9
2004 6
2005 8
2006 8
2007 2
2008 8
2009 7
2010 10
2011 9
2012 10
2013 6
2014 9
2015 10
2016 8
2017 12
2018 13
2019 9
2020 11
2021 5
Text availability
Article attribute
Article type
Publication date

Search Results

168 results
Results by year
Filters applied: . Clear all
Page 1
Paracrine regulation of melanogenesis.
Yuan XH, Jin ZH. Yuan XH, et al. Among authors: jin zh. Br J Dermatol. 2018 Mar;178(3):632-639. doi: 10.1111/bjd.15651. Epub 2018 Jan 16. Br J Dermatol. 2018. PMID: 28494100 Review.
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.
Davies C, Pan H, Godwin J, Gray R, Arriagada R, Raina V, Abraham M, Medeiros Alencar VH, Badran A, Bonfill X, Bradbury J, Clarke M, Collins R, Davis SR, Delmestri A, Forbes JF, Haddad P, Hou MF, Inbar M, Khaled H, Kielanowska J, Kwan WH, Mathew BS, Mittra I, Müller B, Nicolucci A, Peralta O, Pernas F, Petruzelka L, Pienkowski T, Radhika R, Rajan B, Rubach MT, Tort S, Urrútia G, Valentini M, Wang Y, Peto R; Adjuvant Tamoxifen: Longer Against Shorter (ATLAS) Collaborative Group. Davies C, et al. Lancet. 2013 Mar 9;381(9869):805-16. doi: 10.1016/S0140-6736(12)61963-1. Lancet. 2013. PMID: 23219286 Free PMC article. Clinical Trial.
168 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page